Company: OXBRW
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-023960
Chunk: 78

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 78
---
 the transactions
were $435,393. The proceeds from the ATM sales are being used for general corporate purposes.

Subsequent
to June 30, 2025, we have sold 50,000 ordinary shares under the ATM program for gross proceeds of $117,778 at an average price of $2.36
per share. After deducting commissions related to the ATM offering of $3,533, the net proceeds we received from the transactions were
$114,245. The proceeds from the ATM sales are being used for general corporate purposes.

WARRANTS

On
January 29, 2024, the Company extended the expiration date of the warrants (NASDAQ: OXBRW) (the “Warrants”) to 5:00 p.m.
Philadelphia time on the earlier to occur of (a) March 26, 2029 and (b) the date fixed for cancellation by the Company following any
20-trading day period in which the Company’s ordinary shares traded above $9.38 per share for at least ten trading days.

There
were 8,230,700
warrants outstanding at June 30, 2025 and December 31, 2024. One warrant may be exercised to acquire one ordinary share at an
exercise price equal to $7.50
per share on or before March 26, 2029. The Company at its option may cancel the warrants in whole or in part, provided that the
closing price per ordinary share has exceeded $9.38
for at least ten trading days within any period of twenty consecutive trading days, including the last trading day of the period. No
warrants were exercised during the period ended June 30, 2025.

Securities
purchase agreement

On
February 24, 2025, the Company and an institutional investor (the “Investor”) entered into a securities purchase agreement
(the “Securities Purchase Agreement”) relating to the issuance and sale of ordinary shares of the Company pursuant to a registered
direct offering and a private placement of warrants to purchase ordinary shares (collectively, the “Offering”).

The
Investor purchased approximately $3.0 million in the Offering, consisting of an aggregate of 705,884 ordinary shares, Series A Warrants
to purchase up to an aggregate of 529,413 ordinary shares (the “Series A Warrants”) and Series B Warrants to purchase up
to an aggregate of 882,355 ordinary shares (the “